Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques

Magnetic Resonance in Medicine

Volumn 43, Issue 5, 2000, Pages 691-700

  Wirestam, Ronnie ^a   Andersson, Linda ^a   Østergaard, Leif ^b   Bolling, Max ^a   Aunola, Juha Petri ^a   Lindgren, Arne ^a   Geijer, Bo ^a   Holtås, Stig ^a   Ståhlberg, Freddy ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arterial input function; Cerebral blood flow (CBF); Dynamic susceptibility contrast magnetic resonance imaging (MRI); Nonparametric deconvolution

Indexed keywords

DECONVOLUTION; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; SINGULAR VALUE DECOMPOSITION;

ARTERIAL INPUT FUNCTION; CAROTID ARTERY; CEREBRAL BLOOD FLOW; DECONVOLUTION TECHNIQUES; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST MRIS; NON-PARAMETRIC DECONVOLUTION; RESPONSE CURVES;

BLOOD;

GADOLINIUM PENTETATE;

ARTICLE; BRAIN BLOOD FLOW; CALCULATION; CAROTID ARTERY; CONTRAST ENHANCEMENT; DIFFUSION; FOURIER TRANSFORMATION; GRAY MATTER; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PREDICTION; TISSUE PERFUSION;

EID: 0034063886     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(200005)43:5<691::AID-MRM11>3.0.CO;2-B     Document Type: Article

References (31)

1. Wang Z, Su M, Nalcioglu O. Measurement of tumour vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI. Magn Reson Med 1998;40:397-404.
2. Østergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, Weisskoff RM, Gonzalez RG, Gyldensted C, Rosen BR. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300-305.
3. Reimer P, Bremer C, Horch C, Morgenroth C, Allkemper T, Schuierer G. MR-monitored LITT as a palliative concept in patients with high grade gliomas: preliminary clinical experience. J Magn Reson Imaging 1998; 8:240-244.
4. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echo-planar perfusion- and diffusion-weighted MRI. Neurology 1998; 51:418-426.
5. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-943.
6. Sorensen AG, Copen WA, Østergaard L, Buonanno FS, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999;210:519-527.
7. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finkelstein SP, Rosen BR, Koroshetz WJ. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391-401.
8. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997;28: 439-446.
9. Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 1998;50:870-875.
10. Lansberg MG, Tong DC, Norbash AM, Yenari MA, Moseley ME. Intraarterial rtPA treatment of stroke assessed by diffusion- and perfusion-weighted MRI. Stroke 1999;30:678-680.
11. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metabol 1984;4:633-634.
12. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-559.
13. Jacquez JA. Kinetics of distribution of tracer-labeled materials. In: Compartmental analysis in biology and medicine. Amsterdam: Elsevier; 1972. p 84-101.
14. Gobbel GT, Fike JR. A deconvolution method for evaluating indicator-dilution curves. Phys Med Biol 1994;39:1833-1854.
15. Bock JC, Henriksen O, Götze AHG, Wlodarczyk W, Sander B, Felix R. Magnetic resonance perfusion imaging with gadolinium-DTPA: a quantitative approach for the kinetic analysis of first-pass residue curves. Invest Radiol 1995;30:693-699.
16. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193: 637-641.
17. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
18. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen DR. High resolution measurement of cerebral blood flow using intravaseular tracer bolus passages. II. Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
19. Vonken EPA, Beekman FJ, Bakker CJG, Viergever MA. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn Reson Med 1999;41:343-350.
20. Perman WH, Gado MH, Larson KB, Perlmutter JS. Simultaneous MR acquisition of arterial and brain signal-time curves. Magn Reson Med 1992;28:74-83.
21. Köstler H, Becker H. The value of gating and flow compensation for measurements of the arterial input function in dynamic susceptibility contrast MRI. MAGMA 1996;4(Suppl.):68.
22. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, Rosen BR, Brady TJ. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-347.
23. Zierler KL. Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965;16:309-321.
24. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
25. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C, 2nd ed. Cambridge: Cambridge University Press; 1992.
26. Benner T, Heiland S, Erb G, Forsting M, Sartor K. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 1997:15:307-317.
27. Scholdei R, Wenz F, Rempp K, Schreiber W, Fuss M. Essig M, Brix G. Determination of the arterial input function (AIF) in dynamic susceptibility contrast MRI (DSC). In: Proceedings of the ISMRM 4th Annual Meeting, New York, 1996, p 1301.
28. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJR, Gibbs JM, Wise RJS, Hatazawa J, Herold S, Beaney RP, Brooks DJ, Spinks T, Rhodes C, Frackowiak RSJ, Jones T. Cerebral blood flow, blood volume and oxygen utilization. Brain 1990;113:27-47.
29. Vonken EPA, van Osch MJP, Bakker CJG, Viergever MA. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109-117.
30. Østergaard L, Smith DF, Vestergaard-Poulsen P, Hansen SB, Gee AD, Gjedde A, Gyldensted C. Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metabol 1998;18:425-432.
31. 2O positron emission tomography in humans. J Cereb Blood Flow Metabol 1998;18:935-940.